{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:36:09Z","timestamp":1707525369573},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,7]]},"DOI":"10.7759\/cureus.48432","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T12:55:51Z","timestamp":1699361751000},"source":"Crossref","is-referenced-by-count":0,"title":["Systemic Lymphoma Masquerading as Multiple Sclerosis Relapse"],"prefix":"10.7759","author":[{"given":"Lisle W","family":"Blackbourn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffani S","family":"Franada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E","family":"Bach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000622","article-title":"Multiple sclerosis: clinical aspects","volume":"31","author":"Oh J","year":"2018","unstructured":"Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018, 31:752-9. 10.1097\/WCO.0000000000000622","journal-title":"Curr Opin Neurol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.3836","article-title":"Multiple sclerosis - etiology and diagnostic potential","volume":"71","author":"Kami\u0144ska J","year":"2017","unstructured":"Kami\u0144ska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online). 2017, 71:551-63. 10.5604\/01.3001.0010.3836","journal-title":"Postepy Hig Med Dosw (Online)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson AJ","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al.. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018, 17:162-73. 10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee WJ","year":"2017","unstructured":"Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017, 389:1336-46. 10.1016\/S0140-6736(16)30959-X","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s100720100044","article-title":"The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes","volume":"22 Suppl 2","author":"Trojano M","year":"2001","unstructured":"Trojano M, Paolicelli D. The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci. 2001, 22 Suppl 2:S98-102. 10.1007\/s100720100044","journal-title":"Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5045\/br.2022.2022037","article-title":"Basic immunohistochemistry for lymphoma diagnosis","volume":"57","author":"Cho J","year":"2022","unstructured":"Cho J. Basic immunohistochemistry for lymphoma diagnosis. Blood Res. 2022, 57:55-61. 10.5045\/br.2022.2022037","journal-title":"Blood Res"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.98.18_supplement.2526","article-title":"B-cell CNS lymphoma disguised as tumefactive multiple sclerosis relapse in patient on ocrelizumab (p8-4.003)","volume":"98","author":"Carr K","year":"2022","unstructured":"Carr K, Willis M, Sharma S. B-cell CNS lymphoma disguised as tumefactive multiple sclerosis relapse in patient on ocrelizumab (p8-4.003). Neurology. 2022, 98:2526.","journal-title":"Neurology"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/193551-systemic-lymphoma-masquerading-as-multiple-sclerosis-relapse","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:19Z","timestamp":1707509359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/193551-systemic-lymphoma-masquerading-as-multiple-sclerosis-relapse"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.48432","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,7]]}}}